PharmaCCX, Inc. — Form D
PharmaCCX, Inc. of Boston, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-11-27. The offering totals $4.1M, of which $3.3M was reported sold. Industry: Other Technology.
Offering
- Filed: 2018-11-27
- Form: D
- Accession: 0001759780-18-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $4.1M
- Amount sold: $3.3M
- Remaining: $800K
- Investors: 16
- Date of first sale: 2018-11-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-326555
Issuer
- Name: PharmaCCX, Inc.
- CIK: 0001759780
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 867 Boylston Street, Boston, MA, 02116
- Phone: 508-658-9080
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Peter Rice | Executive Officer | Boston, MA |
| Nathan Sigworth | Director | Boston, MA |
| Nathan Sigworth | Executive Officer | Boston, MA |
| Julia Shankar Bernstein | Director | Boston, MA |
| Rob Shankar Kniaz | Director | Boston, MA |
| Barath Shankar Subramanian | Director | Boston, MA |
| Armen Shankar Solakhyan | Executive Officer | Boston, MA |
Other filings by this issuer (2)
More